Similar articles for PMID: 29606543

Year	Number of Results
1991	3
1996	3
1997	1
1998	1
1999	2
2000	2
2001	2
2002	2
2005	1
2006	3
2007	8
2008	1
2009	7
2010	6
2011	8
2012	8
2013	5
2014	5
2015	2
2016	8
2017	8
2018	9
2019	9
2020	6
2021	5
2022	9
2023	3
2024	0

1

A phase I, open-label, single-dose micro tracer mass balance study of ¹⁴C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry.

Miyatake D, Nakada N, Takada A, Kato K, Taniuchi Y, Katashima M, Sawamoto T. Miyatake D, et al. Drug Metab Pharmacokinet. 2018 Apr;33(2):118-124. doi: 10.1016/j.dmpk.2018.03.001. Epub 2018 Mar 7. Drug Metab Pharmacokinet. 2018. PMID: 29606543 Clinical Trial.

2

Excretion balance and pharmacokinetics following a single oral dose of [¹⁴C]-fedratinib in healthy subjects.

Ogasawara K, Xu C, Kanamaluru V, Siebers N, Surapaneni S, Ridoux L, Palmisano M, Krishna G. Ogasawara K, et al. Cancer Chemother Pharmacol. 2020 Aug;86(2):307-314. doi: 10.1007/s00280-020-04121-0. Epub 2020 Aug 3. Cancer Chemother Pharmacol. 2020. PMID: 32748109

3

Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a potent and selective β(3)-adrenoceptor agonist, after oral administration to healthy male volunteers.

Takusagawa S, van Lier JJ, Suzuki K, Nagata M, Meijer J, Krauwinkel W, Schaddelee M, Sekiguchi M, Miyashita A, Iwatsubo T, van Gelderen M, Usui T. Takusagawa S, et al. Drug Metab Dispos. 2012 Apr;40(4):815-24. doi: 10.1124/dmd.111.043588. Epub 2012 Jan 23. Drug Metab Dispos. 2012. PMID: 22269146 Clinical Trial.

4

Absorption, distribution, metabolism, and excretion (ADME) of ¹⁴C-sonidegib (LDE225) in healthy volunteers.

Zollinger M, Lozac'h F, Hurh E, Emotte C, Bauly H, Swart P. Zollinger M, et al. Cancer Chemother Pharmacol. 2014 Jul;74(1):63-75. doi: 10.1007/s00280-014-2468-y. Epub 2014 May 10. Cancer Chemother Pharmacol. 2014. PMID: 24817600

5

A phase I study to assess the mass balance, excretion, and pharmacokinetics of [¹⁴C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors.

Gupta N, Zhang S, Pusalkar S, Plesescu M, Chowdhury S, Hanley MJ, Wang B, Xia C, Zhang X, Venkatakrishnan K, Shepard DR. Gupta N, et al. Invest New Drugs. 2018 Jun;36(3):407-415. doi: 10.1007/s10637-017-0509-1. Epub 2017 Sep 21. Invest New Drugs. 2018. PMID: 28932928 Free PMC article. Clinical Trial.

6

Mass balance study of [14C] rabeprazole following oral administration in healthy subjects.

Setoyama T, Drijfhout WJ, van de Merbel NC, Humphries TJ, Hasegawa J. Setoyama T, et al. Int J Clin Pharmacol Ther. 2006 Nov;44(11):557-65. doi: 10.5414/cpp44557. Int J Clin Pharmacol Ther. 2006. PMID: 17176622 Clinical Trial.

7

Application of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in Humans.

Bhattacharya C, Sandinge AS, Bragg RA, Heijer M, Yan J, Andersson LC, Jurva U, Pelay-Gimeno M, Vaes WHJ, de Ligt RAF, Gränfors M, Amilon C, Lindstedt EL, Menakuru SR, Garkaviy P, Weidolf L, Gopaul VS. Bhattacharya C, et al. Drug Metab Dispos. 2023 Apr;51(4):451-463. doi: 10.1124/dmd.122.001100. Epub 2023 Jan 13. Drug Metab Dispos. 2023. PMID: 36639243

8

Metabolism of the Dual Orexin Receptor Antagonist ACT-541468, Based on Microtracer/ Accelerator Mass Spectrometry.

Muehlan C, Fischer H, Zimmer D, Aissaoui H, Grimont J, Boss C, Croft M, van Gerven J, Krähenbühl S, Dingemanse J. Muehlan C, et al. Curr Drug Metab. 2019;20(4):254-265. doi: 10.2174/1389200220666190206141814. Curr Drug Metab. 2019. PMID: 30727881 Clinical Trial.

9

Pharmacokinetics and metabolism of [¹⁴C]-tozadenant (SYN-115), a novel A2a receptor antagonist ligand, in healthy volunteers.

Mancel V, Mathy FX, Boulanger P, English S, Croft M, Kenney C, Knott T, Stockis A, Bani M. Mancel V, et al. Xenobiotica. 2017 Aug;47(8):705-718. doi: 10.1080/00498254.2016.1221164. Epub 2016 Sep 2. Xenobiotica. 2017. PMID: 27489076 Clinical Trial.

10

Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers.

Paulson SK, Hribar JD, Liu NW, Hajdu E, Bible RH Jr, Piergies A, Karim A. Paulson SK, et al. Drug Metab Dispos. 2000 Mar;28(3):308-14. Drug Metab Dispos. 2000. PMID: 10681375 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year